SCIEX, a renowned global provider of analytical technologies in the life sciences, has unveiled the Echo® MS+ system during SLAS 2024. This cutting-edge system integrates the proprietary Acoustic Ejection Mass Spectrometry technology with Open Port Interface (OPI) sampling, leveraging the features of the SCIEX ZenoTOF 7600 or Triple Quad 6500+ system. The result is the delivery of accurate qualitative and quantitative results across an extended range of robust high-throughput screening workflows.
Addressing key challenges in high-throughput screening applications for drug discovery without the necessity for extensive method development, the Echo® MS+ system introduces flexible workflows for small and large molecules. Leveraging the capabilities of high-resolution mass spectrometry enhances selectivity and sensitivity compared to other analytical tools. The system combines high analysis speed, superior data quality, and minimal sample and reagent consumption, potentially reducing time, cost, and risk during the early stages of the drug development pipeline. This expanded capability empowers researchers to make faster and more confident decisions in hit identification and iterative lead optimization, expediting the drug discovery process and minimizing the potential for false positive or false negative results.
Jose Castro-Perez, Vice President of Product Management at SCIEX, highlighted the technology’s speed and fidelity of results, emphasizing the integration with high-resolution mass spectrometry to develop innovative workflows for various molecule types in high-throughput screening applications. The ongoing collaboration with customers at the global Echo® MS Center of Excellence aims to address critical unmet analytical needs with this disruptive technology.
For further information, visit https://sciex.com/products/integrated-solutions/echo-ms-plus
About SCIEX
SCIEX provides solutions for the precise detection and quantitation of molecules, enabling customers to safeguard and advance wellness and safety. With 50 years at the forefront of mass spectrometry, SCIEX has consistently developed groundbreaking technologies and solutions influencing transformative research and outcomes. Pioneering robust solutions in mass spectrometry and capillary electrophoresis, SCIEX empowers life science experts worldwide to respond rapidly to environmental hazards, comprehend disease-relevant biomarkers, enhance patient care, expedite drug development, and ensure healthier and safer food. As part of Danaher, SCIEX benefits from unmatched expertise, offering solutions that inform critical decisions and positively impact lives.
